Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Renalof Administration in the Treatment of Elderly Patients With Gallstones

NCT01099319 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.

NCT NCT01099319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01099319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Renalof Administration in the Treatment of Elderly Patients With Gallstones
Lead sponsor
Catalysis SL
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2010
Completion date
June 30, 2011
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholelithiasis